Global Companion Diagnostics Market 2014-2018

世界のコンパニオン診断(臨床検査)市場動向(2014-2018)

◆タイトル:Global Companion Diagnostics Market 2014-2018
◆商品コード:TNV4031206
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年3月28日
◆ページ数:62
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥308,000見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界のコンパニオン診断(臨床検査)市場動向(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、主要地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Companion Diagnostics
Companion diagnostics is used to identify suitable patients to whom specific drugs can be administered and it monitors the prognosis of the effects of the drug(s) on the disease. This concept of combining a drug with a diagnostic test is termed predictive medicine or personalized medicine. The companion diagnostic test has the ability to predict disease risk, diagnose disease, and monitor the therapeutic response. The tests enable physicians to make informed decisions on the type of drugs to use and the dosage in order to attempt to reduce the mortality rate of diseases such as cancer and neurodegenerative disorders.
TechNavio’s analysts forecast the Global Companion Diagnostics market will grow at a CAGR of 18.59 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Companion Diagnostics market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of companion diagnostic tests and associated kits provided by the vendors. It also presents the vendor landscape and a corresponding detailed analysis of key five vendors in the Global Companion Diagnostics market. The market is highly fragmented, with the presence of many small and large vendors. It includes vendors that operate across the globe and have a substantial presence in North America and the European Union. In addition, the report discusses the major drivers that influence the growth of the Global Companion Diagnostics market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio’s report, the Global Companion Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Companion Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Abbott Laboratories
• Agilent Technologies Inc.
• bioMérieux SA
• Qiagen N.V.
• Roche Holding AG
Other Prominent Vendors

• 20/20 Genesystems Inc.
• A & G Pharmaceutical Inc.
• AccuTheranostics Inc.
• Alacris Theranostics GmbH
• AutoGenomics Inc.
• Biogenex Laboratories Inc.
• Leica Biosystems GmbH
• Life Technologies Inc.
• Luminex Corp.
• pHLOGISTIX LLC
• Spartan Bioscience Inc.
• TheraDiag S.A.
• Theranostics Health Inc.
• Ventana Medical Systems Inc.
Key Market Driver
• Increasing Focus on Reducing the Cost of Drug Discovery and Development.
• For a full, detailed list, view our report.
Key Market Challenge
• High Cost Associated with the Development of Companion Diagnostics.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in Growth Strategies among Vendors
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

1 Executive Summary
2 List of Abbreviations
3 Scope of the Report
3.1 Market Overview
3.2 Product Offerings
4 Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology
5 Introduction
6 Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 Five Forces Analysis
7 Geographical Segmentation
8 Buying Criteria
9 Market Growth Drivers
10 Drivers and their Impact
11 Market Challenges
12 Impact of Drivers and Challenges
13 Market Trends
14 Trends and their Impact
15 Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Other Prominent Vendors
16 Key Vendor Analysis
16.1 Agilent Technologies Inc.
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Abbott Laboratories
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 bioMérieux SA.
16.3.1 Business Overview
16.3.2 Business Segmentation
16.3.3 Key Information
16.3.4 SWOT Analysis
16.4 Genomic Health Inc.
16.4.1 Business Overview
16.4.2 Business Segmentation
16.4.3 Key Information
16.4.4 SWOT Analysis
16.5 Roche Holding AG
16.5.1 Business Overview
16.5.2 Business Segmentation
16.5.3 Key Information
16.5.4 SWOT Analysis
16.6 Qiagen N.V.
16.6.1 Business Overview
16.6.2 Business Segmentation
16.6.3 Key Information
16.6.4 SWOT Analysis
17 Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global in vitro Diagnostic Market 2013-2018 (US$ billion)
Exhibit 3: Global In vitro Diagnostic Market 2013
Exhibit 4: Global Companion Diagnostics Market 2013-2018 (US$ billion)
Exhibit 5: Comparative Analysis of Y-o-Y Growth Rates of Companion Diagnostic and IVD, Global Markets (2013-2018)
Exhibit 6: Global Companion Diagnostics Market Segmentation by Indication, 2013
Exhibit 7: Global Companion Diagnostics Market Segmentation by Indication, 2013
Exhibit 8: Global Companion Diagnostics Market, By Geography 2013
Exhibit 9: Business Segmentation of Agilent Technologies Inc.
Exhibit 10: Business Segmentation of Abbott Laboratories
Exhibit 11: Business Segmentation of bioMérieux SA.
Exhibit 12: Business Segmentation of Roche Holding AG.
Exhibit 13: Business Segmentation of Qiagen N.V.



【掲載企業】

Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Qiagen N.V., Roche Holding AG, 20/20 Genesystems Inc. , A & G Pharmaceutical Inc., AccuTheranostics Inc., Alacris Theranostics GmbH, AutoGenomics Inc., Biogenex Laboratories Inc., LeicaBiosystems GmbH, Life Technologies Inc., Luminex Corp., pHLOGISTIX LLC, Spartan Bioscience Inc., TheraDiag S.A., Theranostics Health Inc., Ventana Medical Systems Inc.

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のコンパニオン診断(臨床検査)市場動向(2014-2018)]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆